(Q50696171)

English

Clinical trials update: highlights of the scientific sessions of The American College of Cardiology 2002: LIFE, DANAMI 2, MADIT-2, MIRACLE-ICD, OVERTURE, OCTAVE, ENABLE 1 & 2, CHRISTMAS, AFFIRM, RACE, WIZARD, AZACS, REMATCH, BNP trial and HARDBALL.

scientific article published in June 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/12034166

Clinical trials update: highlights of the scientific sessions of The American College of Cardiology 2002: LIFE, DANAMI 2, MADIT-2, MIRACLE-ICD, OVERTURE, OCTAVE, ENABLE 1 & 2, CHRISTMAS, AFFIRM, RACE, WIZARD, AZACS, REMATCH, BNP trial and HARDBALL. (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/12034166

4

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/12034166

author name string

Alison Coletta

1

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/12034166

Simon Thackray

2

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/12034166

Nikolay Nikitin

3

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/12034166

publication date

1 June 2002

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/12034166

European Journal of Heart Failure

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/12034166

4

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/12034166

3

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/12034166

381-388

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/12034166

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900040-5

21 January 2018

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900040-5

21 January 2018

Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900040-5

21 January 2018

Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on Holter and a left ventricular ejection fraction below 30%.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900040-5

21 January 2018

Clinical Trials Update: CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ-2, RECOVER and RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the Scientific Sessions of the American College of Cardiology, 2001.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900040-5

21 January 2018

Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900040-5

21 January 2018

Risk stratification in chronic heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900040-5

21 January 2018

Systematic review of the management of atrial fibrillation in patients with heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900040-5

21 January 2018

Long-term use of a left ventricular assist device for end-stage heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900040-5

21 January 2018

The Carvedilol Hibernation Reversible Ischaemia Trial; Marker of Success (CHRISTMAS)

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900040-5

21 January 2018

Expanding indications for implantable cardiac defibrillators

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900040-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome studies with device therapy in patients with heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900040-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical trials update: Highlights of the Scientific Sessions of Heart Failure 2001, a meeting of the Working Group on Heart Failure of the European Society of Cardiology. CONTAK-CD, CHRISTMAS, OPTIME-CHF

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900040-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1388-9842(02)00040-5

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/12034166

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/12034166

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50696171&oldid=1416747275"